Planta Med 2006; 72(5): 437-441
DOI: 10.1055/s-2005-916239
Original Paper
Natural Product Chemistry
© Georg Thieme Verlag KG Stuttgart · New York

Antimycobacterial Brominated Metabolites from Two Species of Marine Sponges

Maria Fernanda de Oliveira1 , Jaine Honorata Hortolan Luis de Oliveira1 , Fabio C. S. Galetti2 , Ana Olívia de Souza3 , Célio Lopes Silva2 , Eduardo Hajdu4 , Solange Peixinho5 , Roberto G. S. Berlinck1
  • 1Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP, Brazil
  • 2Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
  • 3Laboratório de Bioquímica e Biofísica, Instituto Butantan, São Paulo, SP, Brazil
  • 4Museu Nacional, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
  • 5Departamento de Biologia, Universidade Federal da Bahia, Salvador, BA, Brazil
Further Information

Publication History

Received: August 11, 2005

Accepted: October 6, 2005

Publication Date:
30 January 2006 (online)

Preview

Abstract

A screening of 500 crude extracts of marine invertebrates against the growth of Mycobacterium tuberculosis H37Rv yielded MeOH extracts of the sponges Aplysina cauliformis and Pachychalina sp. with significant activity. Further bioassay-guided fractionation of both crude extracts led to the isolation of four bromine-containing metabolites. The known (+)-fistularin-3 (1) and 11-deoxyfistularin-3 (2), and the new compound 2-(3-amino-2,4-dibromo-6-hydroxyphenyl)acetic acid (3) were isolated from the sponge A. cauliformis, while the new bromotyrosine-derived 3-(3,5-dibromo-4-methoxyphenyl)-2-methoxy-N-methylpropan-1-ammonium (4) was isolated from Pachychalina sp. Compound 4 exhibited weak antimycobacterial activity while compounds 1 - 3 displayed activity against Mycobacterium tuberculosis H37Rv, with MICs of 7.1, 7.3 and 49 μM, respectively. Compounds 1 and 2 also exhibited low cytotoxicity against J744 macrophages, indicating that both 1 and 2 are interesting leads for the development of new anti-tuberculosis agents.

References

Roberto G. S. Berlinck

Instituto de Química de São Carlos

Universidade de São Paulo

CP 780

CEP 13560-970 - São Carlos

SP

Brazil

Phone: +55-16-3373-9954

Fax: +55-16-3373-9952

Email: rgsberlinck@iqsc.usp.br